Veracyte Inc
NASDAQ:VCYT

Watchlist Manager
Veracyte Inc Logo
Veracyte Inc
NASDAQ:VCYT
Watchlist
Price: 37.04 USD -6.3% Market Closed
Market Cap: 2.8B USD
Have any thoughts about
Veracyte Inc?
Write Note

Veracyte Inc
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Veracyte Inc
Total Receivables Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Veracyte Inc
NASDAQ:VCYT
Total Receivables
$48.8m
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
45%
Abbvie Inc
NYSE:ABBV
Total Receivables
$11.5B
CAGR 3-Years
7%
CAGR 5-Years
16%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Total Receivables
$4.6B
CAGR 3-Years
0%
CAGR 5-Years
7%
CAGR 10-Years
5%
Amgen Inc
NASDAQ:AMGN
Total Receivables
$7.3B
CAGR 3-Years
15%
CAGR 5-Years
15%
CAGR 10-Years
12%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Total Receivables
$1.8B
CAGR 3-Years
17%
CAGR 5-Years
32%
CAGR 10-Years
31%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Total Receivables
$6.1B
CAGR 3-Years
4%
CAGR 5-Years
18%
CAGR 10-Years
21%

See Also

What is Veracyte Inc's Total Receivables?
Total Receivables
48.8m USD

Based on the financial report for Sep 30, 2024, Veracyte Inc's Total Receivables amounts to 48.8m USD.

What is Veracyte Inc's Total Receivables growth rate?
Total Receivables CAGR 10Y
45%

Over the last year, the Total Receivables growth was 24%. The average annual Total Receivables growth rates for Veracyte Inc have been 7% over the past three years , 16% over the past five years , and 45% over the past ten years .

Back to Top